| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis B Core Antibody
Message10.2018
Test Code
CPT Codes
86704
Preferred Specimen
Minimum Volume
Transport Container
Transport Temperature
Specimen Stability
Methodology
Chemiluminescent Microparticle Immunoassay (Abbott Architect)
Setup Schedule
Reference Range
Clinical Significance
Antibodies against the hepatitis B virus core antigen of all heavy chain types (measured as total Anti-HBc) are marker of prior contact with hepatitis B virus. In recent infection, the majority of the total Anti-HBc are IgM, which are gradually replaced by IgG. A separate test can specifically determine if IgM antibodies against the hepatitis B virus core antigen (Anti-HBc IgM (HBCM)) are present and can help to interpret clinical situations in which total Anti-HBc are reactive. Total Anti-HBc are reactive in recent infection (Anti-HBc IgM (HBCM) reactive) or remote infection (Anti-HBc IgM (HBCM) non-reactive). Remote infections (i.e. total Anti-HBc (HBCOR) reactive AND Anti-HBc IgM (HBCM) non-reactive) need to be distinguished by a separate test for the hepatitis B virus surface antigen (HBsAg (HBSAG)) into remote cleared infections (HBsAg (HBSAG) non-reactive) and chronic active infections (HBsAg (HBSAG) confirmed positive).
Total anti-HBc are not induced by vaccination and do not convey immunity against infection. Use a separate test for antibodies against hepatitis B virus surface antigen (Anti-HBsAg (HBSAB)) to determine successful vaccination.Typical patterns of Hepatitis B Virus related serum markers
| Marker | No exposure * | Acute infection | Chronic infection ** | Resolved infection | Vaccination |
| HBsAg (HBSAG) | NON-REACTIVE | CONFIRMED POSITIVE | CONFIRMED POSITIVE | NON-REACTIVE | NON-REACTIVE |
| Anti-HBs (HBSAB) | NON-REACTIVE | NON-REACTIVE | NON-REACTIVE | REACTIVE | REACTIVE |
| Anti-HBc IgM (HBCM) | NON-REACTIVE | REACTIVE | NON-REACTIVE | NON-REACTIVE | NON-REACTIVE |
| total Anti-HBc (HBCOR) | NON-REACTIVE | REACTIVE | REACTIVE | REACTIVE | NON-REACTIVE |
** in chronic Infection HBs Ag levels may wane and Anti-HBc IgM may recur in flares

